Samsung Bioepis
About:
Samsung Bioepis is a biopharmaceutical company.
Website: https://www.samsungbioepis.com
Top Investors: Biogen
Description:
Samsung Bioepis Co., Ltd. develops and produces biopharmaceutical and biosimilar products. Samsung Bioepis Co., Ltd. has a strategic collaboration agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2012 and is based in Incheon,
Total Funding Amount:
749B KRW
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
Incheon, Inch'on-jikhalsi, South Korea
Founded Date:
2012-01-01
Contact Email:
bioepisinfo(AT)samsung.com
Founders:
Number of Employees:
501-1000
Last Funding Date:
2018-06-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai